相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Malnutrition and Alcohol in Patients Presenting with Severe Complications of Cirrhosis After Laparoscopic Bariatric Surgery
Yuly P. Mendoza et al.
OBESITY SURGERY (2021)
The Association between Diet and Hepatocellular Carcinoma: A Systematic Review
Elena S. George et al.
NUTRIENTS (2021)
Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients
Wei-Ru Cho et al.
PLOS ONE (2021)
Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending?
Miriam Longo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Dominik Pfister et al.
NATURE (2021)
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
Philip N. Newsome et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Composite Score of Healthy Lifestyle Factors and Risk of Hepatocellular Carcinoma: Findings from a Prospective Cohort Study
Hung N. Luu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Dominik Pfister et al.
NATURE (2021)
Risks of Light and Moderate Alcohol Use in Fatty Liver Disease: Follow-Up of Population Cohorts
Fredrik Aberg et al.
HEPATOLOGY (2020)
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease
Fasiha Kanwal et al.
HEPATOLOGY (2020)
Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies
Fredrik Aberg et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2020)
Gut microbiome in HCC - Mechanisms, diagnosis and therapy
Robert F. Schwabe et al.
JOURNAL OF HEPATOLOGY (2020)
Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials
Marzieh Mahmoodi et al.
PHYTOTHERAPY RESEARCH (2020)
Does adequate physical activity attenuate the associations of alcohol and alcohol-related cancer mortality? A pooled study of 54 686 British adults
Yingyu Feng et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies
Md. Mohaimenul Islam et al.
CANCERS (2020)
Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis
Antonio Facciorusso et al.
CANCERS (2020)
Exercise Attenuates the Transition from Fatty Liver to Steatohepatitis and Reduces Tumor Formation in Mice
Maria Guarino et al.
CANCERS (2020)
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
Tracey G. Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
High-protein diet more effectively reduces hepatic fat than low-protein diet despite lower autophagy and FGF21 levels
Chenchen Xu et al.
LIVER INTERNATIONAL (2020)
Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges
Shen Li et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Effects of the Mediterranean diet on cardiovascular risk factors in non-alcoholic fatty liver disease patients: A systematic review and meta-analysis
Omid Asbaghi et al.
CLINICAL NUTRITION ESPEN (2020)
Mediterranean diet for patients with non-alcoholic fatty liver disease, a systematic review and meta-analysis of observational and clinical investigations
Masoumeh Akhlaghi et al.
JOURNAL OF DIABETES AND METABOLIC DISORDERS (2020)
The effect of a Mediterranean diet on metabolic parameters in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trials
Seyedeh Parisa Moosavian et al.
CLINICAL NUTRITION ESPEN (2020)
Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study
Louise J. M. Alferink et al.
GUT (2019)
Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys A Randomized Clinical Trial
Jeffrey B. Schwimmer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Hepatocellular carcinoma in the setting of alcohol-related liver disease
Nathalie Ganne-Carrie et al.
JOURNAL OF HEPATOLOGY (2019)
Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms
Gyuri Kim et al.
SEMINARS IN LIVER DISEASE (2019)
Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease
Tracey G. Simon et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
Mohsen Malehmir et al.
NATURE MEDICINE (2019)
Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis
Eduardo Vilar-Gomez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Physical Activity and the Risk of Liver Cancer: A Systematic Review and Meta-Analysis of Prospective Studies and a Bias Analysis
Sebastian E. Baumeister et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Aspirin targets P4HA2 through inhibiting NF-κB and LMCD1-AS1/let-7g to inhibit tumour growth and collagen deposition in hepatocellular carcinoma
Tianjiao Wang et al.
EBIOMEDICINE (2019)
REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis
Vlad Ratziu et al.
CONTEMPORARY CLINICAL TRIALS (2019)
Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study
Gregorio Recaredo et al.
NUTRIENTS (2019)
Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis
Yung Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Dietary Patterns and Risk of Hepatocellular Carcinoma Among US Men and Women
Yanan Ma et al.
HEPATOLOGY (2019)
Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis
Shen Li et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2019)
Association between physical activity and risk of hepatobiliary cancers: A multinational cohort study
Sebastian E. Baumeister et al.
JOURNAL OF HEPATOLOGY (2019)
Obeticholic acid: towards first approval for NASH
Mohammed Eslam et al.
LANCET (2019)
Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease
Gemma Aragones et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink?
Maria L. Petroni et al.
NUTRIENTS (2019)
High-Quality Diets Are Associated With Reduced Risk of Hepatocellular Carcinoma and Chronic Liver Disease: The Multiethnic Cohort
David Bogumil et al.
HEPATOLOGY COMMUNICATIONS (2019)
The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
Brandon J. Perumpail et al.
DISEASES (2019)
Endocrine implications of bariatric surgery: a review on the intersection between incretins, bone, and sex hormones
Isabel Casimiro et al.
PHYSIOLOGICAL REPORTS (2019)
Associations between dietary factors and markers of NAFLD in a general Dutch adult population
A. Rietman et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2018)
Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease
Tim Mitchell et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project
Jessica L. Petrick et al.
BRITISH JOURNAL OF CANCER (2018)
Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease
Jiantao Ma et al.
GASTROENTEROLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Pioglitazone and bladder cancer risk: a systematic review and meta-analysis
Huilin Tang et al.
CANCER MEDICINE (2018)
Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy
Murphy L. Y. Wan et al.
HEPATOBILIARY SURGERY AND NUTRITION (2018)
Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases
Jonathan G. Stine et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
Fasiha Kanwal et al.
GASTROENTEROLOGY (2018)
Coffee, Green Tea, and Caffeine Intake and Liver Cancer Risk: A Prospective Cohort Study
Takashi Tamura et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2018)
Association Between Aspirin Use and Risk of Hepatocellular Carcinoma
Tracey G. Simon et al.
JAMA ONCOLOGY (2018)
Anti-Tumoral Effects of Exercise on Hepatocellular Carcinoma Growth
Uttara Saran et al.
HEPATOLOGY COMMUNICATIONS (2018)
Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study
Gyuri Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
The Role of GLP-1 in the Metabolic Success of Bariatric Surgery
Chelsea R. Hutch et al.
ENDOCRINOLOGY (2017)
Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes
Mariya Markova et al.
GASTROENTEROLOGY (2017)
Randomized Controlled Trial of a MUFA or Fiber-Rich Diet on Hepatic Fat in Prediabetes
Isabel Errazuriz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Fruit Fiber Consumption Specifically Improves Liver Health Status in Obese Subjects under Energy Restriction
Irene Cantero et al.
NUTRIENTS (2017)
Coffee Consumption and Risk of Biliary Tract Cancers and Liver Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies
Justyna Godos et al.
NUTRIENTS (2017)
Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis
Oliver John Kennedy et al.
BMJ OPEN (2017)
Dietary factors can protect against liver cancer development
Lemonica Koumbi
WORLD JOURNAL OF HEPATOLOGY (2017)
The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial
Mohsen Razavi Zade et al.
LIVER INTERNATIONAL (2016)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Matthew James Armstrong et al.
LANCET (2016)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Alcohol drinking pattern and risk of alcoholic liver cirrhosis: A prospective cohort study
Gro Askgaard et al.
JOURNAL OF HEPATOLOGY (2015)
Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C
Tracey G. Simon et al.
JOURNAL OF HEPATOLOGY (2015)
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix et al.
LANCET ONCOLOGY (2015)
Insulin and other antidiabetic drugs and hepatocellular carcinoma risk: a nested case-control study based on Italian healthcare utilization databases
Cristina Bosetti et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)
Pioglitazone, a PPAR agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling
Yuan Yang et al.
MOLECULAR CARCINOGENESIS (2015)
Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study
Shuji Sumie et al.
MOLECULAR AND CLINICAL ONCOLOGY (2015)
Statin use and risk of hepatocellular carcinoma in a US population
Katherine A. McGlynn et al.
CANCER EPIDEMIOLOGY (2014)
Overfeeding Polyunsaturated and Saturated Fat Causes Distinct Effects on Liver and Visceral Fat Accumulation in Humans
Fredrik Rosqvist et al.
DIABETES (2014)
Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials
S. Chiu et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2014)
Extrahepatic Platelet-Derived Growth Factor-β, Delivered by Platelets, Promotes Activation of Hepatic Stellate Cells and Biliary Fibrosis in Mice
Shuhei Yoshida et al.
GASTROENTEROLOGY (2014)
Index-Based Dietary Patterns and Risk of Incident Hepatocellular Carcinoma and Mortality From Chronic Liver Disease in a Prospective Study
Wen-Qing Li et al.
HEPATOLOGY (2014)
Mediterranean diet and hepatocellular carcinoma
Federica Turati et al.
JOURNAL OF HEPATOLOGY (2014)
Synergism Between Obesity and Alcohol in Increasing the Risk of Hepatocellular Carcinoma: A Prospective Cohort Study
Rohit Loomba et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Shin Yoshimoto et al.
NATURE (2013)
Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
Shih-Wei Lai et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives Results from a large population-based follow-up study
Rikje Ruiter et al.
DIABETES CARE (2012)
Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus
Chia-Hsuin Chang et al.
HEPATOLOGY (2012)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats
Hui-Lu Zhang et al.
JOURNAL OF HEPATOLOGY (2012)
Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
Helen M. Parker et al.
JOURNAL OF HEPATOLOGY (2012)
Statin Use and the Risk of Liver Cancer: A Population-Based Case-Control Study
Hui-Fen Chiu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression and ROCK
Borna Relja et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Impact of Metformin on the Prognosis of Cirrhosis Induced by Viral Hepatitis C in Diabetic Patients
Gisele Nkontchou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Association of Diabetes Duration and Diabetes Treatment With the Risk of Hepatocellular Carcinoma
Manal M. Hassan et al.
CANCER (2010)
Obesity and Alcohol Synergize to Increase the Risk of Incident Hepatocellular Carcinoma in Men
Rohit Loomba et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 Diabetes
Mariana Lazo et al.
DIABETES CARE (2010)
Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
Kittichai Promrat et al.
HEPATOLOGY (2010)
Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection
Takumi Kawaguchi et al.
LIVER INTERNATIONAL (2010)
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
Valter Donadon et al.
LIVER INTERNATIONAL (2010)
Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2009)
Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer
Yuan-Chin Amy Lee et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2009)
Skeletal consequences of thiazolidinedione therapy
A. Grey
OSTEOPOROSIS INTERNATIONAL (2008)
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials
A. Michael Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Patterns of alcohol drinking and all-cause mortality: Results from a large-scale population-based cohort study in Japan
Tomomi Marugame et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma
JA Marrero et al.
JOURNAL OF HEPATOLOGY (2005)
Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the US
JM Yuan et al.
CANCER (2004)
Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus
MM Hassan et al.
HEPATOLOGY (2002)
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro
A Galli et al.
GASTROENTEROLOGY (2002)
分享论文
